Liewei Wang
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Pharmacology 70
- Pharmacogenetics and Drug Metabolism 70
- Treatment of Major Depression 21
- Genetics 65
- Genetic Associations and Epidemiology 37
- Estrogen and related hormone effects 23
- BRCA gene mutations in cancer 11
- Co-authors
- Richard M. Weinshilboum (121 shared papers)Krishna R. Kalari (61 shared papers)Zhenkun Lou (19 shared papers)Gregory D. Jenkins (33 shared papers)Brooke L. Fridley (29 shared papers)Howard L. McLeod (1 shared paper)Huadong Pei (7 shared papers)Nifang Niu (16 shared papers)
- Journals
- Pharmacogenetics and Genomics (13 papers)Clinical Cancer Research (12 papers)Cancer Research (10 papers)PLoS ONE (10 papers)Breast Cancer Research (8 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Liewei Wang
249 papers receiving 11.7k citations
Liewei Wang's Hit Papers
Peers
Comparison fields: 5 of 155
- Pharmacology 2.4k
- Cancer Research 1.3k
- Oncology 1.3k
- Molecular Biology 3.5k
- Health Informatics 116
Countries citing papers authored by Liewei Wang
This map shows the geographic impact of Liewei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liewei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liewei Wang more than expected).
Fields of papers citing papers by Liewei Wang
This network shows the impact of papers produced by Liewei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liewei Wang. The network helps show where Liewei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liewei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 607 | |
| 2 | Genomics and Drug Response Hit paper breakdown → | 2011 | 489 |
| 3 | 2011 | 342 | |
| 4 | Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention Hit paper breakdown → | 2020 | 308 |
| 5 | 1999 | 305 | |
| 6 | 2017 | 284 | |
| 7 | Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right Dose, Right Time—Using Genomic Data to Individualize Treatment Protocol Hit paper breakdown → | 2014 | 264 |
| 8 | 2004 | 244 | |
| 9 | 2016 | 182 | |
| 10 | 2006 | 179 | |
| 11 | 2017 | 178 | |
| 12 | 2010 | 173 | |
| 13 | 2019 | 171 | |
| 14 | 2005 | 167 | |
| 15 | 2018 | 156 | |
| 16 | 2017 | 150 | |
| 17 | 2008 | 147 | |
| 18 | 2017 | 144 | |
| 19 | 2012 | 142 | |
| 20 | 2019 | 141 |
About Liewei Wang
Liewei Wang is a scholar working on Pharmacology, Genetics, Cancer Research, Molecular Biology and Pharmacology, having authored 251 papers that have together received 12k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (70 papers), Genetic Associations and Epidemiology (37 papers), Breast Cancer Treatment Studies (30 papers), Estrogen and related hormone effects (23 papers), Treatment of Major Depression (21 papers), Prostate Cancer Treatment and Research (16 papers), Bioinformatics and Genomic Networks (14 papers) and BRCA gene mutations in cancer (11 papers). The work is most often cited by research in Pharmacology (2.4k citations), Cancer Research (1.3k citations), Oncology (1.3k citations), Molecular Biology (3.5k citations) and Health Informatics (116 citations). Liewei Wang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Richard M. Weinshilboum, Krishna R. Kalari, Zhenkun Lou, Gregory D. Jenkins, Brooke L. Fridley, Howard L. McLeod, Huadong Pei, Nifang Niu, Liang Li and Jia Yu. Their work appears in journals such as Pharmacogenetics and Genomics, Clinical Cancer Research, Cancer Research, PLoS ONE and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.